Cho SG - Search Results

1

Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.

Qing M, Zhou T, Perova T, Abraham Y, Sweeney C, Krevvata M, Zhang X, Qi M, Gao G, Kim TM, Yao M, Cho SG, Eom HS, Lim ST, Yeh SP, Kwong YL, Yoon DH, Kim JS, Kim WS, Zhou L, Attar R, Verona RI. Qing M, et al. Among authors: cho sg. Ann Hematol. 2024 Jun;103(6):1989-2001. doi: 10.1007/s00277-023-05603-w. Epub 2024 Jan 18. Ann Hematol. 2024. PMID: 38233570 Free PMC article. Clinical Trial.

2

Pilot study of pegylated interferon alpha-2a treatment during chemo- and radiotherapy and post-remission maintenance in patients with EBV-positive extranodal NK/T cell lymphoma.

Kim SY, Cho SG, Kim SW, Choi BO, Park KS, Lim J, Min CK, Kim YG, Lee JW, Min WS. Kim SY, et al. Among authors: cho sg. Ann Hematol. 2011 Jun;90(6):693-9. doi: 10.1007/s00277-010-1114-y. Epub 2010 Nov 19. Ann Hematol. 2011. PMID: 21088967 Clinical Trial.

3

Clinical outcomes of post-remission therapy using (90)yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma.

Han EJ, Lee SE, Kim SH, Sohn HS, Jung SE, Park G, Choi BO, Lee SN, Yang SW, Han K, Cho SG. Han EJ, et al. Among authors: cho sg. Ann Hematol. 2011 Sep;90(9):1075-82. doi: 10.1007/s00277-011-1191-6. Epub 2011 Feb 19. Ann Hematol. 2011. PMID: 21336624 Clinical Trial.

4

Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.

Cho BS, Lim JY, Yahng SA, Lee SE, Eom KS, Kim YJ, Chung NG, Jeong DC, Lee S, Kim HJ, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Min CK. Cho BS, et al. Among authors: cho sg. Ann Hematol. 2012 Mar;91(3):439-48. doi: 10.1007/s00277-011-1318-9. Epub 2011 Sep 6. Ann Hematol. 2012. PMID: 21894475

5

Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).

Lee J, Cho SG, Chung SM, Ryu MR, Kim SH, Jang HS, Choi BO. Lee J, et al. Among authors: cho sg. Ann Hematol. 2013 Mar;92(3):333-43. doi: 10.1007/s00277-012-1630-z. Epub 2012 Nov 21. Ann Hematol. 2013. PMID: 23180438

6

Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.

Kim N, Im KI, Lim JY, Jeon EJ, Nam YS, Kim EJ, Cho SG. Kim N, et al. Among authors: cho sg. Ann Hematol. 2013 Oct;92(10):1295-308. doi: 10.1007/s00277-013-1796-z. Epub 2013 May 31. Ann Hematol. 2013. PMID: 23722500 Review.

7

Plerixafor use for peripheral blood stem cell mobilization in Korea.

Kim SJ, Yoon DH, Yang DH, Eom HS, Cho SG, Yoon SS, Lee JH, Kim WS, Suh C. Kim SJ, et al. Among authors: cho sg. Blood Res. 2013 Jun;48(2):72-3. doi: 10.5045/br.2013.48.2.72. Blood Res. 2013. PMID: 23826573 Free PMC article. No abstract available.

8

Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma.

Lee SE, Kim JH, Jeon YW, Yoon JH, Shin SH, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Lee JW, Min WS, Park CW, Min CK. Lee SE, et al. Among authors: cho sg. Ann Hematol. 2015 Mar;94(3):445-52. doi: 10.1007/s00277-014-2216-8. Epub 2014 Sep 26. Ann Hematol. 2015. PMID: 25257340

9

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation.

Jeong SH, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, Kwak JY, Eom HS, Won JH, Hong JS, Oh SY, Lee HS, Kim SJ. Jeong SH, et al. Among authors: cho sg. Ann Hematol. 2015 Apr;94(4):617-25. doi: 10.1007/s00277-014-2258-y. Epub 2014 Dec 3. Ann Hematol. 2015. PMID: 25465233

10

Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.

Kim JS, Yoon DH, Park S, Yoon SS, Cho SG, Min CK, Lee JJ, Yang DH, Kwak JY, Eom HS, Kim WS, Kim H, Do YR, Moon JH, Lee J, Suh C. Kim JS, et al. Among authors: cho sg. Ann Hematol. 2016 Mar;95(4):603-11. doi: 10.1007/s00277-016-2589-y. Epub 2016 Jan 11. Ann Hematol. 2016. PMID: 26754633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

723 results

Search Page